Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 2, 1998, Pages 179-187

  Doucet Populaire, Florence ^a  

^a Faculty of Medicine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; ERYTHROMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIFFUSION; FRACTIONATION; HIGH RISK PATIENT; HYDROPHOBICITY; INTEGUMENT; MEMBRANE TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PARTITION COEFFICIENT; RIBOSOME;

ANTI-BACTERIAL AGENTS; CHEMICAL FRACTIONATION; CLARITHROMYCIN; ERYTHROMYCIN; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; RIBOSOMES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031920089     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.2.179     Document Type: Article

References (26)

1. Chaisson, R. E., Benson, C. A., Dube, M. P., Heifets, L. B., Korvick, J. A., Elkin, S. et al. (1994). Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Annals of Internal Medicine 121,905-11.
2. Dautzenberg, B., Saint Marc, T., Meyohas, M. C., Eliaszewitch, M., Haniez, F., Rogues, A. M. et al. (1993). Clarithromycin and other antimicrobial agents in the treatment of.disseminated Mycobacterium avium infections in patients wilh, acquired immunodeficiency syndrome. Archives of Internal Medicine 153,368-72.
3. Dautzenberg, B. (1994). Clinical trials in Mycobacterium avium therapy: lessons to take home. Research in Microbiology 145, 197-206. - .
4. Havlir, D. V. (1994). Mycobacterium avium complex: advances in therapy. European Journal of Clinical Microbiology & Infectious Diseases 13,915-24.
5. Moroni, M., Gori, A., Rusconi, S., Franzetti, F. & Antinori, S. (1994). Mycobacterial infections in AIDS: an overview of epidemiology, clinical manifestations, therapy and prophylaxis. Monaldi Archives of Chest Diseases 49,432-6.
6. Connell, N. D. & Nikaido, H. (1994). Membrane permeability and transport in Mycobacterium tuberculosis. In Tuberculosis, Pathogenesis, Protection, and Control (Bloom, B. R., Ed.), pp. 333-52. American Society for Microbiology, Washington, DC.
7. Mamadou, D., Marie-Ange, D. & Nicole, F. (1989). The cell envelope of Mycobacterium smegmatis: cytochemistry and architectural implications. FEMS Microbiology Letters 61,89-93.
8. Minnikin, D. E. (1982). Lipids: complex lipids, their chemistry, biosynthesis and roles. In The Biology of Mycobacteria (Ratledge, C. & Stanford, J., Eds), pp. 95-184. Academic Press, London.
9. Jarlier, V. & Nikaido, H. (1990). Permeability barrier to hydrophilic solutes in Mycobacterium chelonei. Journal of Bacteriology 172, 1418-23.
10. Jarlier, V. & Nikaido, H. (1994). Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiology Letters 123,11 -8.
11. Mizuguchi, Y., Udou, T. & Yamada, T. (1983). Mechanism of antibiotic resistance in Mycobacterium intracellulare. Microbiology and Immunology 27,425-31.
12. Rastogi, N., Frehel, C., Ryter, A., Onayon, H., Lesourd, M. & David, H. L. (1981). Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents? Antimicrobial Agents and Chemotherapy 20, 666-77.
13. Trias, J., Jarlier, V. & Benz, R. (1992). Poriris in the cell wall of mycobacteria. Science258,1479-81.
14. Kakegawa, T., Ogawa, T. & Hirose, S. (1988). Mode of inhibition of protein synthesis by TE-031 (A-56268). Chemotherapy 36, Suppl. 3,123-8.
15. Nagate, T., Ono, T., Sugita, K., Akashi, T., Morikawa, E., Miyazaki, M. et al. (1988). Antibacterial activity of M-5, the most active metabolite of TE-031 (A-56268) in man. Chemotherapy 36, Suppl. 3,156-69.
16. Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T. & Jacobs, W. R. (1990). Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Molecular Microbiology 4,1911-9.
17. Canetti, G., Rist, N. & Grosset, J. (1963). Mesure de la sensibilite du bacille tuberculeux aux drogues antibacillaires par la methode des proportions. Revue de Tuberculose et Pneumologie 27,217-72.
18. Capobianco, J. O. & Goldman, R. C. (1990). Erythromycin and axithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force (AjxH). Antimicrobial Agents and Chemotherapy34, 1787-91.
19. Goldman, R. C., Fesik, S. W. & Doran, C. C. (1990). Role of protonated and neutral forms of macrolides in binding to ribosomes from Gram-positive and Gram-negative bacteria. Antimicrobial Agents and Chemotherapy34,426-31.
20. Goldman, R. C., Zakula, D., Flamm, R., Beyer, J. & Capobianco, J. (1994). Tight binding of clarithromycin, its 14(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrobial Agents andChemotherapySB, 1496-500.
21. Tsuji, A., Kubo, O., Miyamoto, E. & Yamana, T. (1977). Physicochemical properties of β-lactam antibiotics: oil-water distribution. Journal of Pharmaceutical Science 66,1675-9.
22. Haemers, A., Leysen, D. C., Bollaert, W., Zhang, M. Q. & Pattyn, S. R. (1990). Influence of N substitution on antimycobacterial activity of ciprofloxacin. Antimicrobial Agents and Chemotherapy 34,496-7.
23. Rastogi, N., Moreau, B., Capmau, M. L, Goh, K. S. & David, H. L. (1988). Antibacterial action of amphiphatic derivatives of isoniazid against the Mycobacterium avium complex. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene [A] 268,456-62.
24. David, H. L, Clavel-Seres, S., Clement, F. & Coh, K. S. (1987). Uptake of selected antibacterial agents in Mycobacterium avium. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene [A] 265, 385-92.
25. Doucet-Populaire, F., Truffot-Pernot, C.', Grosset, J. & Jarlier, V. (1995). Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin. Journal of Antimicrobial Chemotherapy 36, 129-36.
26. Meier, A., Kirschner, P., Springer, B. Steingrube, V. A., Brown, B. A., Wallace, R. G. etal. (1994). Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrobial Agents and Chemotherapy 38,381-4.